Cytotoxic T lymphocytes (CTL) against alphavirus-infected L929 cells were generated in mice by two in vivo immunizations of one virus or by m cit,o immunization followed by in tJitro stimulation of splenocytes with infected peritoneal exudate cells or splenocytes. These CTL caused specific H-2-restricted cytolysis equally well with homologous, heterologous or Sindbis virus ts20 mutant-infected cells. Thus, specific CTL appear to be cross-reactive components in normal immunity to alphaviruses and the E1 glycoprotein is implicated as the target antigen.
. In other experiments, C3H mice were immunized twice with SIN or SF, as described above and elsewhere (Wolcott et al., 1982 a) , with secondary immunization carried out 14 days after primary immunization. Four days after secondary immunization, T-enriched splenocytes were prepared and immediately assayed for cytolytic activity on target cells. All target cell assays involving SIN ts20 were performed at restrictive temperature, 40 °C. The stock SIN ts20 was plaque-purified four times and titrated at 4 × 109 p.f.u./ml at the permissive temperature of 30 °C. Reversion frequency was determined as 10-5/ml. SIN or SF immune effectors from secondary stimulation in vitro by infected PEC were assayed for their ability to lyse virus-infected target cells. Two representative experiments are shown in Table 1 . Effector cells efficiently lysed virus-infected syngeneic (L929) cells but not allogeneic (A31) cells, suggesting that effector cells were CTL. Failure of effector cells to lyse A31 target ceils was not attributable to lack of viral surface antigen or to inherent resistance to cytolysis, since infected A31 cells were equally or more susceptible than L929 cells to lysis by antiviral antibody plus complement (data not shown). The effector cells from stimulation in vitro expressed both Thy 1 and Lyt 2. t antigens, since treatment of effector cells with rabbit antimouse T cell serum or mouse monoclonal anti-Lyt 2.1 antibody and Low-Tox-M rabbit complement (Accurate Chemical & Scientific, Westbury, N.Y., U.S.A.) before addition to target cells reduced cytotoxicity to insignificant levels.
Alphavirus CTL generated by immunization and stimulation in vitro with a single alphavirus were shown to lyse syngeneic target cells infected with the same virus or with an alphavirus ~" Effector:target ratio yielding maximal cytolysis. E :T ratios greater than 50:I were not tested. :~ The amount of st Cr release from uninfected ceils ( ~< 4 ~/o) was subtracted from the observed release of infected cells, belonging to a different subgroup (Table 1) . These data support those of Mullbacher et al. (1979) and our previous reports (Gates et al., 1982; Wolcott et al., 1982a; Peck et al., 1979) on crossreactivity of alphavirus-induced CTL.
These data demonstrate the ability of alphavirus-induced CTL to lyse syngeneic target cells infected with SIN ts20. Both homologous (SIN, expt. a, part 1) and heterologous (SF, expt. a, part 2) virus-induced CTL recognized SIN ts20-infected targets when assayed at restrictive temperature.
Unlabelled target competition studies were performed with wild-type virus-or SIN ts20-infected competitor cells and wild-type-infected, 51Cr-labeUed target cells mixed with SIN or SF effector cells. Inhibition of cytolysis increased with increasing numbers of competitor cells, using 1 : 1, 5 : 1 and 10 : 1 ratios of competitor to target (data not shown), At a ratio of 10 : 1, after subtracting the percent inhibition of cytolysis by uninfected competitors, SIN ts20-infected competitors produced a 22~o to 38~ inhibition of cytolysis of wild-type-infected target cells. Over a series of triplicate experiments, inhibition by SIN ts20-infected competitors was comparable to that observed with competitors infected with wild-type virus (data not shown).
At restrictive temperature, SIN ts20-infected cells are known to express only the E1 glycoprotein at the plasma membrane surface (Strauss & Strauss, 1980; Bell & Waite, 1977; Bracha & Schlesinger, 1976; Smith & Brown, 1977) . We found that rabbit anti-E 1 serum, but not anti-E2 serum, will cause cytolysis of SIN ts20-infected L929 cells in antibody-dependent, complement-mediated cytotoxicity assays (data not shown). Thus, the evidence supports the interpretation that E 1 glycoprotein serves as a target antigen for homologous and cross-reactive alphavirus-immune CTL. Cross-reactivity of E 1 has been previously demonstrated in antibodymediated reactions involving cytolysis (Wolcott et al., 1982b) , immunoblotting (Wolcott et al., 1984) , immunoprecipitation (Wolcott et al., 1984) , and haemagglutination-inhibition (Gates et al., 1982) .
In addition to homologous and cross-cytolysis of alphavirus-infected targets by CTL stimulated in vitro, effector cells stimulated by immunization in vivo similarly lysed syngeneic target cells (Table 2; Wolcott et al., 1982a) .
These data and previous reports (Peck et al., 1975; Gates et at., 1982; Wolcott et aI., 1982a Wolcott et aI., , b, 1984 Mullbacher et al., 1979; Peck et al., 1979; King et al., 1977) suggest a role for cross-reactive CTL in alphavirus-induced cross-protection in vivo and further implicates E1 glycoprotein as one of the target antigens in protection.
